Advocates at the advisory council urged the national Parkinson's plan to establish a federal 'time‑critical' designation for levodopa medications under CMS, and to mandate a 15‑minute administration window in acute and long‑term care, plus specialized staff training. The request was framed as a patient‑safety measure after caregivers described dangerous medication timing under current rules.